Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Beam Therapeutics (BEAM) Other Non Operating Income: 2019-2024

Historic Other Non Operating Income for Beam Therapeutics (BEAM) over the last 6 years, with Dec 2024 value amounting to $2.3 million.

  • Beam Therapeutics' Other Non Operating Income fell 1278.50% to -$2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $522,000, marking a year-over-year increase of 4.40%. This contributed to the annual value of $2.3 million for FY2024, which is 69.71% down from last year.
  • Beam Therapeutics' Other Non Operating Income amounted to $2.3 million in FY2024, which was down 69.71% from $7.5 million recorded in FY2023.
  • Over the past 5 years, Beam Therapeutics' Other Non Operating Income peaked at $23.9 million during FY2022, and registered a low of -$63.4 million during FY2020.
  • For the 3-year period, Beam Therapeutics' Other Non Operating Income averaged around $11.2 million, with its median value being $7.5 million (2023).
  • In the last 5 years, Beam Therapeutics' Other Non Operating Income plummeted by 1,074.07% in 2020 and then surged by 2,490.00% in 2022.
  • Yearly analysis of 5 years shows Beam Therapeutics' Other Non Operating Income stood at -$63.4 million in 2020, then surged by 98.42% to -$1.0 million in 2021, then skyrocketed by 2,490.00% to $23.9 million in 2022, then crashed by 68.62% to $7.5 million in 2023, then slumped by 69.71% to $2.3 million in 2024.